{"transactions":[{"id":1828344,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":110687,"kind":"person","name":"WAGNER RICHARD W","position":1,"cik":"0001277280","reported_name":"WAGNER RICHARD W","relationship":{"director":true}}],"security":"Warrants (right to buy)","published_at":"2023-07-18T20:15:11.000Z","date":"2023-07-13","kind":"purchase","planned":false,"acquired":true,"shares":83916,"price":0.125,"value":10489.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on July 13, 2023, pursuant to which, on July 14, 2023, the reporting person acquired $120,000 principal amount of the Issuer's 6.0% Senior Convertible Promissory Notes due July 2028 (the \"Notes\") and (ii) 83,916 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.005 per share (\"Common Stock\"), at an exercise price of $2.61 per share (the \"Warrants\"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof. The conversion price for each Note included $0.25 ($0.125 for each Warrant share) in accordance with Nasdaq rules."}],"balance_after":83916,"derivative":{"exercise_price":2.61,"exercise_date":"2023-07-14","expiration_date":"2028-07-14","underlying":"Common Stock","underlying_shares":83916},"source":{"system":"sec-edgar","filing":"0001140361-23-034994","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036123034994/form4.xml","form_type":"4"}},{"id":1828343,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":110687,"kind":"person","name":"WAGNER RICHARD W","position":1,"cik":"0001277280","reported_name":"WAGNER RICHARD W","relationship":{"director":true}}],"security":"6.0% Senior Convertible Promissory Notes due 2028","published_at":"2023-07-18T20:15:11.000Z","date":"2023-07-13","kind":"purchase","planned":false,"acquired":true,"price":120000,"reported_value":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on July 13, 2023, pursuant to which, on July 14, 2023, the reporting person acquired $120,000 principal amount of the Issuer's 6.0% Senior Convertible Promissory Notes due July 2028 (the \"Notes\") and (ii) 83,916 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.005 per share (\"Common Stock\"), at an exercise price of $2.61 per share (the \"Warrants\"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof. The conversion price for each Note included $0.25 ($0.125 for each Warrant share) in accordance with Nasdaq rules."}],"derivative":{"exercise_price":2.86,"exercise_date":"2023-07-14","expiration_date":"2028-07-14","underlying":"Common Stock","underlying_shares":41958},"source":{"system":"sec-edgar","filing":"0001140361-23-034994","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036123034994/form4.xml","form_type":"4"}}]}